Editorial Methodology

MVP Peptides publishes research-focused peptide education for readers who want sources, context, and limits stated clearly. Our method starts with primary literature and ends with editorial review before a page goes live. The process is designed to reduce unsupported claims, separate human data from preclinical findings, and keep research-only language visible.

Sources We Use

Source selection starts with materials that can be checked by a reader. We prefer primary research and official records over summaries, forums, or marketing pages.

• PubMed-indexed peer-reviewed journals
• FDA prescribing information for approved peptide drugs
• ClinicalTrials.gov records for active or completed trials
• Manufacturer-published research when it includes methods and data
• NCBI Bookshelf, NIH, and similar public medical references

How We Grade Evidence

Each claim is matched to the evidence behind it. Randomized controlled trials and systematic reviews carry more weight than animal studies, in-vitro work, or mechanistic hypotheses. Our evidence levels page explains how we label study types and why preclinical findings need cautious wording.

Citation Requirements

Health-related claims need a source that readers can inspect. When possible, citations include a PMID, DOI, journal landing page, or government record. External citation links are checked at publish time, and broken links are replaced with a stable source only when the replacement still points to the same study or official record.

Editorial Review

Every page is reviewed by the MVP Peptides editorial team before publication. Review focuses on citation fit, medical claim strength, research-only labeling, contraindication context, and whether a page could be mistaken for medical advice. YMYL pages and flagged safety content are reviewed at least every 180 days.

Update Policy

Pages are updated when new primary literature, prescribing information, regulatory notices, or safety signals change the context. When a material new source appears, we aim to update affected pages within 30 days. Page bylines show the last reviewed date, and the review widget shows when the next review is due.

Limits

MVP Peptides does not provide medical advice, diagnosis, treatment instructions, or personalized health guidance. We do not endorse a specific protocol. Vendor references are educational and should not be read as medical or legal approval. Research peptides discussed on this site are not approved for human use unless a page explicitly identifies an FDA-approved drug and context.

How To Report A Correction

Readers can review our Editorial Policy for correction standards and update practices. The Medical Review Policy explains how health-related claims are checked, and the About page gives more background on the site.